The mission of the Center for Translational Molecular Imaging (CTMI), a section within the Division of Nuclear Medicine and Molecular Imaging at Johns Hopkins, is to serve as an Academic Research Organization (ARO) to develop and provide state-of-the-art imaging and therapeutic agents to address unmet medical needs to bring personalized medicine within the reach of patients. In the CTMI, we address a variety of disorders including cancer, psychiatric and neurodegenerative diseases, cardiovascular disease, among others. On-site human 3T MRI and positron emission computed tomography/computed tomography (PET/CT) are available.

The CTMI was established to answer challenges in the translation of promising new imaging agents and medicines, which despite their promise to deliver personalized medicine, have no ready commercial backing in the early stages of development. We are specifically designed to undertake initial phase 1 (first-in-human) trials, and address the challenges of moving new molecular imaging or companion therapeutic agents to the clinic. In collaboration with JHMI, we can provide MRI/PET/SPECT imaging services for all clinical trials.

CTMI leverages discoveries from investigators at Johns Hopkins, other academic institutions and industry, turning them into clinical applications as rapidly as possible through our nimble, and clinically focused operating procedures. CTMI is led by a team of highly-qualified, results-oriented individuals with key complementary skills for clinical translation of imaging agents and theranostics.

As an ARO, the CTMI actively solicits industrial collaborations and sponsorship to bring valuable new agents to clinical fruition in a timely manner. As a unique ARO, we cut across traditional silos by bridging academic and commercial missions.

Leveraging resources at Johns Hopkins University, the CTMI will generate new products through the offices of Technology Ventures and Business Development and Strategic Alliances.

Learn more about the CTMI at www.jhctmi.org.

Clinical and Research Services

CTMI focuses on the translation of promising new imaging agents and theranostics into clinical practice. CTMI's goal is to progress scientific results into clinical application as rapidly as possible – for more accurate diagnosis of disease and the creation of personalized patient therapies.

The CTMI utilizes cutting-edge equipment to provide a wide array of services to benefit innovative treatments:

• MRI Services
• Radiopharmaceuticals Services

Contact Information

Phone: 410-955-2789
Mobile: 443-956-5055

Make a Gift

Your generous support helps to fund the latest advancements in radiological technology. Your charitable gift helps us to innovate as we work toward new, more revealing perspectives on the human body, advance our understanding of disease, and discover new treatment methods that improve outcomes for patients at Johns Hopkins and around the world.